Cannabix Technologies Inc. (C:BLO)
Business Focus: Advanced Medical Equipment & Technology (NEC)
| Sector: Healthcare | Industry: Advanced Medical Equipment & Technology |
| Company Contact | |
| Address: | 501-3292 Production Way BURNABY BC V5A 4R4 |
| Tel: | N/A |
| Website: | https://cannabixtechnologies.com |
| IR: | See website |
| Key People | ||
| Ravinder S. Mlait Chief Executive Officer, Director | Bryan E. Loree Chief Financial Officer, Secretary, Director | |
| Business Overview |
| Cannabix Technologies Inc. is a Canada-based developer of marijuana and alcohol breath testing devices. The Company's primary business is the development of marijuana breathalyzer technology. It is developing technologies to detect Tetrahydrocannabinol (THC) in breath samples for law enforcement, employers and laboratories. In addition, it is developing non-contact alcohol screening devices targeted primarily for workplace settings. The MS Breath Sampler (MSBS) is specialized laboratory hardware developed by the Company to confirm THC in breath from humans. The MSBS is a method for collection of analytes of low volatility from human breath utilizing liquid secondary adsorption. Within the Breath Collection Unit (THC detection), the sample is captured inside a cartridge and loaded into the MSBS. In preliminary testing, the system has detected and confirmed THC in breath out to four hours after smoking with breath samples being stored and analyzed up to two days after sample collection. |
| Financial Overview |
| For the nine months ended 31 January 2024, Cannabix Technologies Inc revenues was not reported. Net loss increased 8% to C$1.9M. Higher net loss reflects Stock-based compensation increase from C$210K to C$521K (expense), Professional fees increase of 80% to C$63K (expense). Basic Earnings per Share excluding Extraordinary Items remained flat at -C$0.02. |
| Reporting Currency: | Canadian Dollars |
| Enterprise value: | $45.03M as of Jan 31, 2024 |
| Annual revenue (TTM): | $0.00M as of Jan 31, 2024 |
| EBITDA (TTM): | -$2.23M as of Jan 31, 2024 |
| Net annual income (TTM): | -$2.29M as of Jan 31, 2024 |
| Free cash flow (TTM): | -$1.78M as of Jan 31, 2024 |
| Net Debt Last Fiscal Year: | N/A |
| Shares outstanding: | 114,144,104 as of Jan 31, 2024 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.